Nicola Hughes

2.3k total citations
26 papers, 1.1k citations indexed

About

Nicola Hughes is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Nicola Hughes has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Nicola Hughes's work include Carcinogens and Genotoxicity Assessment (8 papers), DNA and Nucleic Acid Chemistry (4 papers) and Click Chemistry and Applications (3 papers). Nicola Hughes is often cited by papers focused on Carcinogens and Genotoxicity Assessment (8 papers), DNA and Nucleic Acid Chemistry (4 papers) and Click Chemistry and Applications (3 papers). Nicola Hughes collaborates with scholars based in United States, Switzerland and Canada. Nicola Hughes's co-authors include David H. Phillips, Denis M. Grant, Susan A. Janezic, Andrea Gaedigk, Geoffrey H. GOODFELLOW, Michael A.S. Jewett, P. Erbel, Karina L. McQueen, Douglas A. Bell and Trisha Castranio and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and The Lancet Oncology.

In The Last Decade

Nicola Hughes

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicola Hughes United States 17 624 390 230 118 113 26 1.1k
F Zajdela France 21 820 1.3× 429 1.1× 81 0.4× 191 1.6× 62 0.5× 94 1.7k
Michael B. Otteneder Switzerland 17 417 0.7× 174 0.4× 97 0.4× 100 0.8× 45 0.4× 33 859
Manabu Nukaya United States 17 454 0.7× 179 0.5× 522 2.3× 115 1.0× 23 0.2× 30 1.4k
Robert Irons United States 20 463 0.7× 444 1.1× 169 0.7× 82 0.7× 17 0.2× 47 1.6k
Lesley A. Stanley United Kingdom 23 723 1.2× 303 0.8× 71 0.3× 367 3.1× 63 0.6× 41 1.7k
Kenneth L. Dooley United States 16 494 0.8× 526 1.3× 46 0.2× 73 0.6× 45 0.4× 30 1.1k
Els M. de Groene Netherlands 14 354 0.6× 186 0.5× 43 0.2× 83 0.7× 54 0.5× 22 865
Wan‐Mohaiza Dashwood United States 18 756 1.2× 183 0.5× 96 0.4× 176 1.5× 15 0.1× 30 1.3k
Constance C. Weis United States 20 552 0.9× 377 1.0× 67 0.3× 121 1.0× 29 0.3× 33 1.4k
Anthony M. Lynch United Kingdom 24 817 1.3× 933 2.4× 49 0.2× 202 1.7× 36 0.3× 51 1.7k

Countries citing papers authored by Nicola Hughes

Since Specialization
Citations

This map shows the geographic impact of Nicola Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Hughes more than expected).

Fields of papers citing papers by Nicola Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Hughes. The network helps show where Nicola Hughes may publish in the future.

Co-authorship network of co-authors of Nicola Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Hughes. A scholar is included among the top collaborators of Nicola Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Hughes. Nicola Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Nicola, et al.. (2024). The hidden barriers to using cancer registration data. The Lancet Oncology. 25(11). 1390–1391.
2.
Dekker, Carien, Henri Mattes, Michael Wright, et al.. (2021). Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition. Journal of Molecular Biology. 433(24). 167309–167309. 101 indexed citations
3.
Quancard, Jean, Théo Klein, Shan‐Yu Fung, et al.. (2019). An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient. Nature Chemical Biology. 15(3). 304–313. 41 indexed citations
4.
Grosche, Philipp, Finton Sirockin, A. Mac Sweeney, et al.. (2014). Structure-based design and optimization of potent inhibitors of the adenoviral protease. Bioorganic & Medicinal Chemistry Letters. 25(3). 438–443. 15 indexed citations
5.
Wiesmann, Christian, Lukas Leder, Jutta Blank, et al.. (2012). Structural Determinants of MALT1 Protease Activity. Journal of Molecular Biology. 419(1-2). 4–21. 72 indexed citations
6.
Hughes, Nicola, et al.. (2009). Assessing the Matrix Effects of Hemolyzed Samples in Bioanalysis. Bioanalysis. 1(6). 1057–1066. 46 indexed citations
7.
Hughes, Nicola, et al.. (2007). Determination of carryover and contamination for mass spectrometry-based chromatographic assays. The AAPS Journal. 9(3). E353–E360. 102 indexed citations
8.
Washington, Carla, et al.. (2007). Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology. 47(10). 1320–1326. 12 indexed citations
9.
Hughes, Nicola, Witold Winnik, Jean‐Jacques Dunyach, et al.. (2003). High‐sensitivity quantitation of cabergoline and pergolide using a triple‐quadrupole mass spectrometer with enhanced mass‐resolution capabilities. Journal of Mass Spectrometry. 38(7). 743–751. 17 indexed citations
11.
Vaziri, S. A., Nicola Hughes, Heather Sampson, et al.. (2001). Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects. Pharmacogenetics. 11(1). 7–20. 33 indexed citations
12.
Hughes, Nicola, Susan A. Janezic, Karina L. McQueen, et al.. (1998). Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics. 8(1). 55–66. 108 indexed citations
13.
Lin, Henry J., Nicole Probst‐Hensch, Nicola Hughes, et al.. (1998). Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics. 8(3). 269–269. 70 indexed citations
14.
Grant, Denis M., et al.. (1997). Human acetyltransferase polymorphisms. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 376(1-2). 61–70. 206 indexed citations
15.
Hughes, Nicola, et al.. (1993). Covalent binding of polycyclic aromatic hydrocarbon components of coal tar to DNA in mouse skin. Carcinogenesis. 14(1). 135–144. 32 indexed citations
16.
Hughes, Nicola & David H. Phillips. (1993). 32P-Postlabelling analysis of the covalent binding of benzo[ghi]perylene to DNA in vivo and in vitro. Carcinogenesis. 14(1). 127–133. 16 indexed citations
17.
Pfau, Wolfgang, Nicola Hughes, P.L. Grover, & David H. Phillips. (1992). HPLC separation of 32P-postlabelled benzo[b]fluoranthene-DNA adducts. Cancer Letters. 65(2). 159–167. 9 indexed citations
18.
Jankowiak, Ryszard, et al.. (1992). Evidence of involvement of multiple sites of metabolism in the in vivo covalent binding of dibenzo[a,h]pyrene to DNA. Chemical Research in Toxicology. 5(6). 765–772. 12 indexed citations
19.
Hughes, Nicola & David H. Phillips. (1991). Covalent binding of the dibenzpyrenes and benzo[a]pyrene to DNA: evidence for synergistic and inhibitory interactions when applied in combination to mouse skin. Mutation Research/Environmental Mutagenesis and Related Subjects. 252(2). 190–190. 6 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026